Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that preferentially affects individuals of advanced age. Heritability estimates for AD range between 60 and 80%, but only few genetic risk factors have been identified so far. In the present explorative study, we aimed at characterizing the genetic contribution to late-onset AD in participants of the Vienna Transdanube Aging (VITA) longitudinal birth cohort study in a two-step approach. First, we performed a genome-wide screen of pooled DNA samples (n = 588) to identify allele frequency differences between AD patients and non-AD individuals using life-time diagnoses made at the age of 80 (t = 60 months). This analysis suggested a high proportion of brain-expressed genes required for cell adhesion, cell signaling and cell morphogenesis, and also scored in known AD risk genes. In a second step, we confirmed associations using individual genotypes of top-ranked markers examining AD diagnoses as well as the dimensional scores: FULD and MMSE determined up to the age of 82.5 (t = 90 months). Taken together, our study proposes genes ANKS1B, ENST00000414107, LOC100505811, SLC22A14, QRFPR, ZDHHC8P1, ADAMTS3 and PPFIA1 as possible new candidates involved in the etiology of late-onset AD, with further research being needed to clarify their exact roles.
Similar content being viewed by others
References
Abraham R, Moskvina V, Sims R, Hollingworth P, Morgan A, Georgieva L, Dowzell K, Cichon S, Hillmer AM, O’Donovan MC et al (2008) A genome-wide association study for late-onset Alzheimer’s disease using DNA pooling. BMC Med Genomics 1:44
Allen Institute for Brain Science (2016) Allen Brain Atlas. http://www.brain-map.org/. Accessed 13 Feb 2016
Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An english translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat 8(6):429–431
Ashford JW, Mortimer JA (2002) Non-familial Alzheimer’s disease is mainly due to genetic factors. J Alzheimers Dis 4(3):169–177
Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B et al (2014) Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging 35(Suppl 2):S74–S78
Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA (2012) Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69(5):493–498
Bartl J, Scholz CJ, Hinterberger M, Jungwirth S, Wichart I, Rainer MK, Kneitz S, Danielczyk W, Tragl KH, Fischer P et al (2011) Disorder-specific effects of polymorphisms at opposing ends of the insulin degrading enzyme gene. BMC Med Genet 12:151
Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG et al (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer’s disease and related dementias. PLoS Genet 10(9):e1004606
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1):17–23
Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68(2):270–281
Butterfield DA, Di Domenico F, Barone E (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta 1842(9):1693–1706
Cooper JK (2014) Nutrition and the brain: what advice should we give? Neurobiol Aging 35(Suppl 2):S79–S83
Davis OS, Plomin R, Schalkwyk LC (2009) The SNPMaP package for R: a framework for genome-wide association using DNA pooling on microarrays. Bioinformatics 25(2):281–283
Fischer P, Jungwirth S, Krampla W, Weissgram S, Kirchmeyr W, Schreiber W, Huber K, Rainer M, Bauer P, Tragl KH (2002) Vienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation. J Neural Transm Suppl 62:105–116
Fischer P, Zehetmayer S, Jungwirth S, Weissgram S, Krampla W, Hinterberger M, Torma S, Rainer M, Huber K, Hoenigschnabl S et al (2008) Risk factors for Alzheimer dementia in a community-based birth cohort at the age of 75 years. Dement Geriatr Cogn Disord 25(6):501–507
Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40(7):812
Fuld PA (1980) Guaranteed stimulus-processing in the evaluation of memory and learning. Cortex 16(2):255–271
Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168–174
Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10):R80
Ghersi E, Vito P, Lopez P, Abdallah M, D’Adamio L (2004) The intracellular localization of amyloid beta protein precursor (AbetaPP) intracellular domain associated protein-1 (AIDA-1) is regulated by AbetaPP and alternative splicing. J Alzheimers Dis 6(1):67–78
Grünblatt E, Schlosser R, Fischer P, Fischer MO, Li J, Koutsilieri E, Wichart I, Sterba N, Rujescu D, Moller HJ et al (2005) Oxidative stress related markers in the “VITA” and the centenarian projects. Neurobiol Aging 26(4):429–438
Grünblatt E, Hupp E, Bambula M, Zehetmayer S, Jungwirth S, Tragl KH, Fischer P, Riederer P (2006a) Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the “VITA” study. J Affect Disord 96(1–2):111–116
Grünblatt E, Loffler C, Zehetmayer S, Jungwirth S, Tragl KH, Riederer P, Fischer P (2006b) Association study of the 5-HTTLPR polymorphism and depression in 75-Year-Old nondemented subjects from the Vienna Transdanube Aging (VITA) study. J Clin Psychiatry 67(9):1373–1378
Grünblatt E, Reif A, Jungwirth S, Galimberti D, Weber H, Scarpini E, Sauer C, Wichart I, Rainer MK, Huber K et al (2011) Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer’s disease: the VITA and Milano studies. J Psychiatr Res 45(9):1250–1256
Guerreiro R, Bras J, Hardy J (2013) SnapShot: genetics of Alzheimer’s disease. Cell 155(4):968–968, e961
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093
Hohman TJ, Bell SP, Jefferson AL (2015) Alzheimer’s disease neuroimaging I: the role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease. JAMA Neurol 72(5):520–529
Hollingworth P, Harold D, Jones L, Owen MJ, Williams J (2011a) Alzheimer’s disease genetics: current knowledge and future challenges. Int J Geriatr Psychiatry 26(8):793–802
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V et al (2011b) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet 43(5):429–435
Homer N, Tembe WD, Szelinger S, Redman M, Stephan DA, Pearson JV, Nelson SF, Craig D (2008) Multimarker analysis and imputation of multiple platform pooling-based genome-wide association studies. Bioinformatics 24(17):1896–1902
International HapMap C, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P et al (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164):851–861
Jacob AL, Jordan BA, Weinberg RJ (2010) Organization of amyloid-beta protein precursor intracellular domain-associated protein-1 in the rat brain. J Comp Neurol 518(16):3221–3236
Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppanen VM, Holopainen T, Kivela R, Ortega S, Karpanen T, Alitalo K (2014) CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation. Circulation 129(19):1962–1971
Jiao B, Liu X, Zhou L, Wang MH, Zhou Y, Xiao T, Zhang W, Sun R, Waye MM, Tang B et al (2015) Polygenic analysis of late-onset Alzheimer’s disease from Mainland China. PLoS One 10(12):e0144898
Jordan BA, Fernholz BD, Khatri L, Ziff EB (2007) Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons. Nat Neurosci 10(4):427–435
Jordan KW, Craver KL, Magwire MM, Cubilla CE, Mackay TF, Anholt RR (2012) Genome-wide association for sensitivity to chronic oxidative stress in Drosophila melanogaster. PLoS One 7(6):e38722
Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH et al (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 17(13):1951–1953
Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63(3):287–303
Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458
Le Goff C, Somerville RP, Kesteloot F, Powell K, Birk DE, Colige AC, Apte SS (2006) Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis. Development 133(8):1587–1596
Lee DK, Nguyen T, Lynch KR, Cheng R, Vanti WB, Arkhitko O, Lewis T, Evans JF, George SR, O’Dowd BF (2001) Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 275(1):83–91
Macgregor S, Visscher PM, Montgomery G (2006) Analysis of pooled DNA samples on high density arrays without prior knowledge of differential hybridization rates. Nucleic Acids Res 34(7):e55
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34(7):939–944
Musicco M (2009) Gender differences in the occurrence of Alzheimer’s disease. Funct Neurol 24(2):89–92
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 43(5):436–441
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS et al (2014) Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol 71(11):1394–1404
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575
Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11(2):111–128
R Core Team (2015) R: a language and environment for statistical computing. 3.2.0 edn. R Foundation for Statistical Computing
Reif A, Grünblatt E, Herterich S, Wichart I, Rainer MK, Jungwirth S, Danielczyk W, Deckert J, Tragl KH, Riederer P et al (2011) Association of a functional NOS1 promoter repeat with Alzheimer’s disease in the VITA cohort. J Alzheimers Dis 23(2):327–333
Scholz CJ, Jungwirth S, Danielczyk W, Weber H, Wichart I, Tragl KH, Fischer P, Riederer P, Deckert J, Grünblatt E (2014) Investigation of association of serotonin transporter and monoamine oxidase-A genes with Alzheimer’s disease and depression in the VITA study cohort: a 90-month longitudinal study. Am J Med Genet B Neuropsychiatr Genet 165B(2):184–191
Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832–1840
Slomnicki LP, Lesniak W (2008) A putative role of the amyloid precursor protein intracellular domain (AICD) in transcription. Acta Neurobiol Exp (Wars) 68(2):219–228
Spangler SA, Hoogenraad CC (2007) Liprin-alpha proteins: scaffold molecules for synapse maturation. Biochem Soc Trans 35(Pt 5):1278–1282
Stern Y (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 11(11):1006–1012
Takayasu S, Sakurai T, Iwasaki S, Teranishi H, Yamanaka A, Williams SC, Iguchi H, Kawasawa YI, Ikeda Y, Sakakibara I et al (2006) A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice. Proc Natl Acad Sci USA 103(19):7438–7443
Tosto G, Reitz C (2013) Genome-wide association studies in Alzheimer’s disease: a review. Curr Neurol Neurosci Rep 13(10):381
Vucicevic D, Schrewe H, Orom UA (2014) Molecular mechanisms of long ncRNAs in neurological disorders. Front Genet 5:48
Weissflog L, Scholz CJ, Jacob CP, Nguyen TT, Zamzow K, Gross-Lesch S, Renner TJ, Romanos M, Rujescu D, Walitza S et al (2013) KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol 23(6):436–447
Acknowledgements
We thank all participants of the VITA study and their families. We credit the excellent technical assistance of Miryame Hofmann, Terri Töppner and Margarete Göbel.
Author information
Authors and Affiliations
Contributions
CJS and HW performed data analysis; SJ, WD, KHT and PF were involved in participant recruitment and coordinated the cohort study; HW and AR generated genotyping data; PR, JD and EG supervised the study, CJS, JD and EG wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Informed consent
The VITA study was carried out with the permission of the Ethics Committee of the City of Vienna, Austria and conforms to the Declaration of Helsinki; each participant provided written informed consent.
Conflict of interest
The authors declare that they have no competing interests.
Funding
This work has been funded by the Ludwig Boltzmann Institute of Aging Research (Vienna, Austria) and the Alzheimer Forschung Initiative e.V. (AFI) with Grant 09802 to EG. CJS is supported by the Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Grant Z-6.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Scholz, CJ., Weber, H., Jungwirth, S. et al. Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort. J Neural Transm 125, 77–87 (2018). https://doi.org/10.1007/s00702-017-1796-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-017-1796-6